Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 18:8:686.
doi: 10.3389/fneur.2017.00686. eCollection 2017.

Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management

Affiliations
Review

Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management

Maria Antonia Quera Salva et al. Front Neurol. .

Abstract

Several aspects of human physiology and behavior are dominated by 24-h circadian rhythms with key impacts on health and well-being. These include mainly the sleep-wake cycle, vigilance and performance patterns, and some hormone secretions. The rhythms are generated spontaneously by an internal "pacemaker," the suprachiasmatic nuclei within the anterior hypothalamus. This master clock has, for most humans, an intrinsic rhythm slightly longer than 24 h. Daily retinal light exposure is necessary for the synchronization of the circadian rhythms with the external 24-h solar environment. This daily synchronization process generally poses no problems for sighted individuals except in the context of jetlag or working night shifts being conditions of circadian desynchrony. However, many blind subjects with no light perception had periodical circadian desynchrony, in the absence of light information to the master clock leading to poor circadian rhythm synchronization. Affected patients experience cyclical or periodic episodes of poor sleep and daytime dysfunction, severely interfering with social, academic, and professional life. The diagnosis of Non-24 Sleep-Wake Rhythm Disorder, also named free-running disorder, non-entrained disorder, or hypernycthemeral syndrome, remains challenging from a clinical point of view due to the cyclical symptoms and should be confirmed by measurements of circadian biomarkers such as urinary melatonin to demonstrate a circadian period outside the normal range. Management includes behavioral modification and melatonin. Tasimelteon, a novel melatonin receptor 1 and 2 agonist, has demonstrated its effectiveness and safety with an evening dose of 20 mg and is currently the only treatment approved by the FDA and the European Medicines Agency.

Keywords: blind; circadian; clock; light; melatonin; sleep; tasimelteon.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Reinberg A, Halberg F. Circadian chronopharmacology. Annu Rev Pharmacol (1971) 11(1):455–92.10.1146/annurev.pa.11.040171.002323 - DOI - PubMed
    1. Reinberg AE. Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol (1992) 32(1):51–66.10.1146/annurev.pa.32.040192.000411 - DOI - PubMed
    1. Guillaumond F, Dardente H, Giguère V, Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms (2005) 20(5):391–403.10.1177/0748730405277232 - DOI - PubMed
    1. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet (2006) 15(Review Issue 2):R271–7.10.1093/hmg/ddl207 - DOI - PubMed
    1. Shearman LP, Sriram S, Weaver DR, Maywood ES, Chaves I, Zheng B, et al. Interacting molecular loops in the mammalian circadian clock. Science (2000) 288(5468):1013–9.10.1126/science.288.5468.1013 - DOI - PubMed